Daily Notifications as on 24th July 2020

https://www.bseindia.com/markets/MarketInfo/DispNewNoticesCirculars.aspx?page=20200724-42

1. Scrip code : 538564
Name : James Warren Tea Limited
Subject : Corporate Action-Intimation of Buy back
This is to inform you that pursuant to Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, a Meeting of the Board of Directors of the Company will be held on Saturday, the 25th day of July, 2020 at 11:00 A.M. inter-alia, amongst other matters,to consider the proposal of buyback of equity shares of Rs.10/- each fully paid, of the Company.

2. Scrip code : 532500
Name : Maruti Suzuki India Ltd.
Subject : Introduction Of Infotainment System In Ignis Zeta MT & AMT Variants
Dear Sir, You are kindly informed that Ignis Zeta MT & AMT variants now come with the Smartplay Studio Infotainment System. The applicable ex-showroom price in Delhi and NCR region are : Ignis Zeta MT at Rs. 5,97,820/- and Ignis Zeta AMT at Rs. 6,44,820/-. The same is effective from today i.e. 23rd July, 2020.

India Cements Ltd – 24 July 2020

India Cements Ltd

Cements & Cement Products

FV – Rs 10; 52wks H/L – 140/67.9; TTQ – 2.60 Lacs; C    MP – Rs 118 (As On July 24, 2020);

Market Cap – Rs 3668 Crs

Consolidated Financials and Valuations (Amt in Rs Crs unless specified)

 

India Cement
Year Equity Capital Net Worth  Debt Total Sales PAT BV EPS P/E P/BV Promoter’s Holdings
Rs Cr. Rs Cr. Rs Cr. Rs Cr. Rs Cr. Rs Rs %
 

 FY20

310 5498 3163 5228 53 177 1.71 69 0.67 28.27
FY19 310 5246 3048 5809 25 169 0.82 161.57 0.78 28.30

India Cements Ltd asserted that the management in the company was stable and it would continue its focus on cement business. (https://www.thehindubusinessline.com/companies/india-cements-posts-loss-in-q4-full-year-on-covid-19-impact/article31904718.ece#)

Overview:

  • The India Cements Ltd. is a pioneer enterprise during the post-independence era to become a public limited company.
  • From a two plant company having a capacity of just 1.3 million tonnes in 1989, India Cements has robustly grown in the last two decades to a total capacity of 15.5 million tonnes per annum.
  • After the approval of a Scheme of Amalgamation and arrangement between Trinetra Cement Ltd and Trishul Concrete Products Ltd with The India Cements Ltd, all the cement assets have come under one roof – India Cements. India Cements has now 8 integrated cement plants in Tamil Nadu, Telangana, Andhra Pradesh and Rajasthan and two grinding units, one each in Tamil Nadu and Maharashtra.
  • The company has 13 subsidiaries controlled through shareholdings in such Companies, none of which is material.

 

The performance of the Company was also in line with the improved performance of the industry with increase in clinker production, cement production and sales which are as under:

Particulars 2019 2018 % Growth
  (In Lakh Tonnes)  
Clinker Production 91.59 80.09 14
Cement Production 123.11 111.15 11
Cement Sales 122.83 111.5 10
Clinker Sales 1.57 0.26 504
Total Sales 124.4 111.76 11

Mr. N. Srinivasan is the Vice Chairman & MD of the company.

Shareholding Pattern:

Major Holdings:

Non – Promoters No. of shares held % shares held
Subdaram Mutual Fund 7188453 2.32
ELM Park Fund Ltd 17361746 5.6
LIC 14576741 4.71
Radhakishan S Damani 33452777 10.8
Gopikishan S Damani 25601589 8.26
Radhakishan S Damani & Gopikishan S Damani 4145103 1.34
Sri Saradha Logistics Pvt. Ltd 20621843 6.66

 

Share Price Trend:

Price Snapshot:

Year Open (Rs.) High (Rs.) Low (Rs.) Close (Rs.)
2010 124.5 143.15 95 107.65
2011 107.25 112.8 62.1 65.95
2012 66.1 118.5 65.05 90.75
2013 91.3 95 43 60.1
2014 59.8 134.3 46 85.4
2015 86.5 115.8 63.6 85.4
2016 97.55 164 64 116.65
2017 117.4 226 117.4 182.6
2018 184.6 205.9 80.05 96.1
2019 96.2 116.9 67.9 71.4
2020 71.25 140 69.55 119.95

 

Financials:

The sales volume increased by 10% during the year while the gross realisation per ton of cement was lower on account of lower selling price resulting in only a marginal improvement in the top line.

Peer Comparison:

India Cement Ultratech Cements Shree Cements Birla Corporation
Price (Rs) 118 3779 21343 560
FV (Rs) 10 10 10 10
Market Cap 4081 109093 77007 4312
Equity 310 289 36 77
Net Worth 5498 39115 13169 4806
Total Debt 3163 21353 2349 3753
Sales 5228 42773 13143 7001
Net Profit 53 5810 1544 505
EPS (Rs) 1.71 201.3 428 65.6
BV (Rs) 177 1355 3650 624
PE 69 18.8 49.8 8.5
PB 0.67 2.8 5.8 0.9
Capacity (MT) 15.5 111.4 40.4 15.5
Realization Per Tonne 3650 4750 4648 4712

 

Iol Chemicals and Pharmaceuticals Ltd.

Iol Chemicals and Pharmaceuticals Ltd.

Pharmaceuticals

FV – Rs 10; 52wks H/L – 833.40/147.35; TTQ – 2.5 Lacs; CMP – Rs 737.65 (As On July 24, 2020);                   

      Market Cap – Rs 4300.91 Crs

Consolidated Financials and Valuations (Amt in Rs Crs unless specified)

Year Equity Capital Net Worth Long Term Debt Total Sales PAT BV EPS P/E P/BV Promoter’s Holdings
Rs Cr. Rs Cr. Rs Cr. Rs Cr. Rs Cr. Rs Rs %
2020 57 814 56 1894 361 143.00 63.51 11.62 5.16 43.69
2019 57 474 258 1685 237 83.38 41.61 17.73 8.85 41.89

 

About the Company:

IOLCP is India’s one of the leading generic pharmaceutical company, and is a significant player in the Organic chemicals space. IOLCP has a wide presence across various therapeutic categories like, Pain Management, Anti-diabetic, Anti hypertensive, AntiConvulsants, etc.

The company deals in APIs(Active Pharmaceutical Ingredients) and Speciality Chemicals 

It has an API capacity of 12000 TPA which is roughly 34.2% of India’s total API capacity.

API:

In the API division the company presently has a commercial distribution in 6 products: 

  1. Ibuprofen (nonsteroidal anti-inflammatory drug -NSAID)
  2. Metformin Hydrochloride (mainly used to control high blood sugar)
  3. Lamotrigine ( used to treat epilepsy and bipolar disorder)
  4. Fenofibrate ( used to reduce the amounts of cholesterol and triglycerides in the blood) 
  5. Clopidogrel Bi sulphate ( Stimulates platelets aggression)
  6. Ursodeoxycholic acid ( used to reduce the amounts of cholesterol)

They have 10 more products in the advance stage of development 

Speciality Chemicals:

  1. Ethyl Acetate (Paints, Varnishes, Cleaning Mixtures)
  2. Iso Butyl Benzene ( manufacture of Ibuprofen)
  3. Acetyl Chloride ( used in organic synthesis and dyes)
  4. Mono Chloro Acetic Acid ( used to make plastics, pharmaceuticals, flavors, cosmetics)

Board of Directors:

  1. Rajender Mohan Malla (Chairman and Independent Director)
  2. Varinder Gupta (Managing Director)
  3. Vijay Garg (Joint Managing Director)

 

Shareholding Pattern:

Price History:

Peer Comparison:

(All Figures in Rs Cr. unless specified)

IOLCP Granules Divis Solara
Price (Rs) 737.65 280.3 2397.25 650.5
FV (Rs) 10 1 2 10
Market Cap 4300.91 7127 63639 1747
Equity 57 25 53 27
Net Worth 814 1844 7310 1086
Total Debt 56 793 34 587
Sales 1894 2599 5394 1322
Net Profit 361 335 388 115
EPS (Rs) 63.5 13.2 14.6 42.6
BV (Rs) 143.0 72.5 275.4 404.3
PE 11.6 21.2 163.9 15.3
PB 5.2 3.9 8.7 1.6
API Capacity (TPA) 12000 4800 5000